Loading...
UHS delivered solid performance in Q2 2025, driven by higher Medicaid reimbursements and growth across both acute and behavioral health segments.
Reported revenue rose to $4.28B, up from $3.91B in Q2 2024.
Net income increased to $353.2M, with EPS at $5.43.
Acute care and behavioral health both saw revenue and patient day growth.
Strong cash position with $137.6M in cash and equivalents at quarter end.
UHS raised its full-year 2025 forecast for revenue, adjusted EPS, and adjusted EBITDA due to improved Medicaid reimbursements and strong performance in core operations.